drugset / Trial / NCT00002774

Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

NCT00002774

RandomizedParallel-groupTreatment

Summary

PURPOSE: Randomized phase 2 trial to compare the effectiveness of chemo-radiation therapy (RT + cisplatin + 5-FU) with or without tirapazamine for the treatment of patients with stage III or IV squamous cell carcinomas of the head and neck cancer (SCCHN). RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. Tirapazamine may increase the effectiveness of chemotherapy and radiation therapy by making tumor cells more sensitive to therapy.

Timeline

Start
1996-06
Primary completion
2000-06
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject tirapazamine Small molecule 160 mg/m2 Other
Subject tirapazamine Small molecule 220 mg/m2 Other
Subject tirapazamine Small molecule 260 mg/m2 Other
Background Cisplatin Other / unclassified 20 mg/m2 Intravenous
Background fluorouracil Small molecule 600 mg/m2 Other